25 October 2018
October 9, 2018 - Second medical indication and SPC - Referral to the CJEU
Second medical indication and SPC - Referral to the CJEU - Gérard Dossmann, French IP and European patent attorney comments the decision of the Paris Court of Appeal of 9 october 2018 referring questions to the CJEU for a preliminary ruling on the interpretation of Article 3d) of Regulation (EC) No 469/2009 in the light of the NEURIM judgment (CJEU C-130/11).
Background
The subject of the SANTEN’s patent:
The use of a submicron oil-in-water ophthalmic emulsion comprising an immunosuppressive agent selected from the group (...)